TIMP-1 Inhibits apoptosis in lung adenocarcinoma cells via interaction with Bcl-2

Srilatha Nalluri, Sampa Ghoshal-Gupta, Ammar Kutiyanawalla, Sitaram Gayatri, Byung Rho Lee, Shahanawaz Jiwani, Amyn Mohammed Rojiani, Mumtaz V Rojiani

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Tissue inhibitors of metalloproteinases (TIMPs) are multifaceted molecules that exhibit properties beyond their classical proteinase inhibitory function. Although TIMP-1 is a known inhibitor of apoptosis in mammalian cells, the mechanisms by which it exerts its effects are not well-established. Our earlier studies using H2009 lung adenocarcinoma cells, implanted in the CNS, showed that TIMP-1 overexpressing H2009 cells (HB-1), resulted in more aggressive tumor kinetics and increased vasculature. The present study was undertaken to elucidate the role of TIMP-1 in the context of apoptosis, using the same lung cancer cell lines. Overexpressing TIMP-1 in a lung adenocarcinoma cell line H2009 resulted in an approximately 3-fold increased expression of Bcl-2, with a marked reduction in apoptosis upon staurosporine treatment. This was an MMP-independent function as a clone expressing TIMP-1 mutant T2G, lacking MMP inhibition activity, inhibited apoptosis as strongly as TIMP1 overexpressing clones, as determined by inhibition of PARP cleavage. Immunoprecipitation of Bcl-2 from cell lysates also co-immunoprecipitated TIMP-1, indicative of an interaction between these two proteins. This interaction was specific for TIMP-1 as TIMP-2 was not present in the Bcl-2 pull-down. Additionally, we show a co-dependency of TIMP-1 and Bcl-2 RNA and protein levels, such that abrogating Bcl-2 causes a downregulation of TIMP-1 but not TIMP-2. Finally, we demonstrate that TIMP-1 dependent inhibition of apoptosis occurs through p90RSK, with phosphorylation of the pro-apoptotic protein BAD at serine 112, ultimately reducing Bax levels and increasing mitochondrial permeability. Together, these studies define TIMP-1 as an important cancer biomarker and demonstrate the potential TIMP-1 as a crucial therapeutic target.

Original languageEnglish (US)
Article numbere0137673
JournalPLoS One
Volume10
Issue number9
DOIs
StatePublished - Sep 14 2015

Fingerprint

Tissue Inhibitor of Metalloproteinase-1
metalloproteinases
adenocarcinoma
Cell Communication
apoptosis
lungs
Apoptosis
cells
Tissue Inhibitor of Metalloproteinase-2
Cells
Matrix Metalloproteinases
Adenocarcinoma of lung
tissues
Clone Cells
Tissue Inhibitor of Metalloproteinases
Cell Line
Apoptosis Regulatory Proteins
Phosphorylation
Staurosporine
cell lines

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Nalluri, S., Ghoshal-Gupta, S., Kutiyanawalla, A., Gayatri, S., Lee, B. R., Jiwani, S., ... Rojiani, M. V. (2015). TIMP-1 Inhibits apoptosis in lung adenocarcinoma cells via interaction with Bcl-2. PLoS One, 10(9), [e0137673]. https://doi.org/10.1371/journal.pone.0137673

TIMP-1 Inhibits apoptosis in lung adenocarcinoma cells via interaction with Bcl-2. / Nalluri, Srilatha; Ghoshal-Gupta, Sampa; Kutiyanawalla, Ammar; Gayatri, Sitaram; Lee, Byung Rho; Jiwani, Shahanawaz; Rojiani, Amyn Mohammed; Rojiani, Mumtaz V.

In: PLoS One, Vol. 10, No. 9, e0137673, 14.09.2015.

Research output: Contribution to journalArticle

Nalluri, S, Ghoshal-Gupta, S, Kutiyanawalla, A, Gayatri, S, Lee, BR, Jiwani, S, Rojiani, AM & Rojiani, MV 2015, 'TIMP-1 Inhibits apoptosis in lung adenocarcinoma cells via interaction with Bcl-2', PLoS One, vol. 10, no. 9, e0137673. https://doi.org/10.1371/journal.pone.0137673
Nalluri S, Ghoshal-Gupta S, Kutiyanawalla A, Gayatri S, Lee BR, Jiwani S et al. TIMP-1 Inhibits apoptosis in lung adenocarcinoma cells via interaction with Bcl-2. PLoS One. 2015 Sep 14;10(9). e0137673. https://doi.org/10.1371/journal.pone.0137673
Nalluri, Srilatha ; Ghoshal-Gupta, Sampa ; Kutiyanawalla, Ammar ; Gayatri, Sitaram ; Lee, Byung Rho ; Jiwani, Shahanawaz ; Rojiani, Amyn Mohammed ; Rojiani, Mumtaz V. / TIMP-1 Inhibits apoptosis in lung adenocarcinoma cells via interaction with Bcl-2. In: PLoS One. 2015 ; Vol. 10, No. 9.
@article{3c60f4414b20466cad65fedb2fc647c4,
title = "TIMP-1 Inhibits apoptosis in lung adenocarcinoma cells via interaction with Bcl-2",
abstract = "Tissue inhibitors of metalloproteinases (TIMPs) are multifaceted molecules that exhibit properties beyond their classical proteinase inhibitory function. Although TIMP-1 is a known inhibitor of apoptosis in mammalian cells, the mechanisms by which it exerts its effects are not well-established. Our earlier studies using H2009 lung adenocarcinoma cells, implanted in the CNS, showed that TIMP-1 overexpressing H2009 cells (HB-1), resulted in more aggressive tumor kinetics and increased vasculature. The present study was undertaken to elucidate the role of TIMP-1 in the context of apoptosis, using the same lung cancer cell lines. Overexpressing TIMP-1 in a lung adenocarcinoma cell line H2009 resulted in an approximately 3-fold increased expression of Bcl-2, with a marked reduction in apoptosis upon staurosporine treatment. This was an MMP-independent function as a clone expressing TIMP-1 mutant T2G, lacking MMP inhibition activity, inhibited apoptosis as strongly as TIMP1 overexpressing clones, as determined by inhibition of PARP cleavage. Immunoprecipitation of Bcl-2 from cell lysates also co-immunoprecipitated TIMP-1, indicative of an interaction between these two proteins. This interaction was specific for TIMP-1 as TIMP-2 was not present in the Bcl-2 pull-down. Additionally, we show a co-dependency of TIMP-1 and Bcl-2 RNA and protein levels, such that abrogating Bcl-2 causes a downregulation of TIMP-1 but not TIMP-2. Finally, we demonstrate that TIMP-1 dependent inhibition of apoptosis occurs through p90RSK, with phosphorylation of the pro-apoptotic protein BAD at serine 112, ultimately reducing Bax levels and increasing mitochondrial permeability. Together, these studies define TIMP-1 as an important cancer biomarker and demonstrate the potential TIMP-1 as a crucial therapeutic target.",
author = "Srilatha Nalluri and Sampa Ghoshal-Gupta and Ammar Kutiyanawalla and Sitaram Gayatri and Lee, {Byung Rho} and Shahanawaz Jiwani and Rojiani, {Amyn Mohammed} and Rojiani, {Mumtaz V}",
year = "2015",
month = "9",
day = "14",
doi = "10.1371/journal.pone.0137673",
language = "English (US)",
volume = "10",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "9",

}

TY - JOUR

T1 - TIMP-1 Inhibits apoptosis in lung adenocarcinoma cells via interaction with Bcl-2

AU - Nalluri, Srilatha

AU - Ghoshal-Gupta, Sampa

AU - Kutiyanawalla, Ammar

AU - Gayatri, Sitaram

AU - Lee, Byung Rho

AU - Jiwani, Shahanawaz

AU - Rojiani, Amyn Mohammed

AU - Rojiani, Mumtaz V

PY - 2015/9/14

Y1 - 2015/9/14

N2 - Tissue inhibitors of metalloproteinases (TIMPs) are multifaceted molecules that exhibit properties beyond their classical proteinase inhibitory function. Although TIMP-1 is a known inhibitor of apoptosis in mammalian cells, the mechanisms by which it exerts its effects are not well-established. Our earlier studies using H2009 lung adenocarcinoma cells, implanted in the CNS, showed that TIMP-1 overexpressing H2009 cells (HB-1), resulted in more aggressive tumor kinetics and increased vasculature. The present study was undertaken to elucidate the role of TIMP-1 in the context of apoptosis, using the same lung cancer cell lines. Overexpressing TIMP-1 in a lung adenocarcinoma cell line H2009 resulted in an approximately 3-fold increased expression of Bcl-2, with a marked reduction in apoptosis upon staurosporine treatment. This was an MMP-independent function as a clone expressing TIMP-1 mutant T2G, lacking MMP inhibition activity, inhibited apoptosis as strongly as TIMP1 overexpressing clones, as determined by inhibition of PARP cleavage. Immunoprecipitation of Bcl-2 from cell lysates also co-immunoprecipitated TIMP-1, indicative of an interaction between these two proteins. This interaction was specific for TIMP-1 as TIMP-2 was not present in the Bcl-2 pull-down. Additionally, we show a co-dependency of TIMP-1 and Bcl-2 RNA and protein levels, such that abrogating Bcl-2 causes a downregulation of TIMP-1 but not TIMP-2. Finally, we demonstrate that TIMP-1 dependent inhibition of apoptosis occurs through p90RSK, with phosphorylation of the pro-apoptotic protein BAD at serine 112, ultimately reducing Bax levels and increasing mitochondrial permeability. Together, these studies define TIMP-1 as an important cancer biomarker and demonstrate the potential TIMP-1 as a crucial therapeutic target.

AB - Tissue inhibitors of metalloproteinases (TIMPs) are multifaceted molecules that exhibit properties beyond their classical proteinase inhibitory function. Although TIMP-1 is a known inhibitor of apoptosis in mammalian cells, the mechanisms by which it exerts its effects are not well-established. Our earlier studies using H2009 lung adenocarcinoma cells, implanted in the CNS, showed that TIMP-1 overexpressing H2009 cells (HB-1), resulted in more aggressive tumor kinetics and increased vasculature. The present study was undertaken to elucidate the role of TIMP-1 in the context of apoptosis, using the same lung cancer cell lines. Overexpressing TIMP-1 in a lung adenocarcinoma cell line H2009 resulted in an approximately 3-fold increased expression of Bcl-2, with a marked reduction in apoptosis upon staurosporine treatment. This was an MMP-independent function as a clone expressing TIMP-1 mutant T2G, lacking MMP inhibition activity, inhibited apoptosis as strongly as TIMP1 overexpressing clones, as determined by inhibition of PARP cleavage. Immunoprecipitation of Bcl-2 from cell lysates also co-immunoprecipitated TIMP-1, indicative of an interaction between these two proteins. This interaction was specific for TIMP-1 as TIMP-2 was not present in the Bcl-2 pull-down. Additionally, we show a co-dependency of TIMP-1 and Bcl-2 RNA and protein levels, such that abrogating Bcl-2 causes a downregulation of TIMP-1 but not TIMP-2. Finally, we demonstrate that TIMP-1 dependent inhibition of apoptosis occurs through p90RSK, with phosphorylation of the pro-apoptotic protein BAD at serine 112, ultimately reducing Bax levels and increasing mitochondrial permeability. Together, these studies define TIMP-1 as an important cancer biomarker and demonstrate the potential TIMP-1 as a crucial therapeutic target.

UR - http://www.scopus.com/inward/record.url?scp=84947546483&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947546483&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0137673

DO - 10.1371/journal.pone.0137673

M3 - Article

C2 - 26366732

AN - SCOPUS:84947546483

VL - 10

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 9

M1 - e0137673

ER -